Francisco Mojica spent the entire 1990s trying to understand a bizarre repeating pattern in salt pond archaea DNA. His eventual discovery — that bacteria have an adaptive immune system that remembers past virus infections — was rejected by four top journals before publication. That system is now CRISPR, and it just received FDA approval as a therapy for sickle cell disease.